Summary.-It has been shown that lymphocytes isolated from the peripheral blood of patients with chronic lymphocytic leukaemia do not modify the mustard group of chlorambucil, as has been demonstrated previously in Yoshida ascites cells. However, lymphocytes from patients with an unsatisfactory clinical course or poor response to treatment were able to modify the aromatic region of the drug molecule; little change occurred in the aromatic absorption of intracellular chlorambucil in patients who responded to treatment. This simple test may provide a rapid assessment of a patient's potential response to chemotherapy.
]DIFFERENCES in the utilization of chlorambucil following its uptake by cells in vitro have been demonstrated using an experimental animal tumour system (Harrap and Hill, 1970) : cells of a drugresistant strain of the Yoshida ascites sarcoma were capable of hydrolysing the chloroethyl groups and modifying the aromatic ring of the drug more extensively than drug-sensitive cells. These 2 effects led to the maintenance of a higher level of unmodified drug in sensitive cells compared with resistant cells. These studies have now been extended to lymphocytes isolated from the peripheral blood of patients with chronic lymphocytic leukaemia; if chlorambucil were metabolized similarly in lymphocytes, this mechanism might account in part for the failure of such patients to respond to treatment. P_ A_ Drug uptake was followed by withdrawing 2 ml aliquots of cell suspension at measured time intervals after drug addition. An ethanolic cell extract was prepared as described previously (Harrap and Hill, 1970) . The " total " drug content of these extracts was determined by E258 measurements using a chlorambucil standard curve prepared under the same experimental conditions; this provided an estimate of chlorambucil moieties containing an intact benzene ring. The proportion of drug containing functional mustard groups, " active " drug, was determined by a modification of the colorimetric procedure of Epstein, Rosenthal 
MATERIALS AND METHODS

Chlorambucil
RESULTS
The rate of uptake of chlorambucil by lymphocytes, and its subsequent hydrolysis, is shown in cells isolated from the blood of several patients in Fig. 1 Fig. 2 shows that the benzenoid component of the drug remained unmodified in aqueous solution, and in the cells from some patients (Class I). However, a second group of patients (Class II) was distinguished by a progressive decrease in the aromatic absorption of intracellular drug. The accumulated data are listed in Table I , together with clinical details of all the patients studied.
DISCUSSION
The data reported here may be compared with those of a previous study on drug-sensitive and -resistant strains of the Yoshida ascites sarcoma (Harrap and Hill, 1970) . The latter work indicated that the chlorambucil molecule was modified in the mustard group, and also in the benzene ring, by both cell types. However, these 2 reactions were considerably more extensive in the drug-resistant cell strain. In the present work, the mustard group of chlorambucil remained unmodified by CLL lymphocytes. It was also notable that these cells took up only approximately 10% of that amount of drug accumulated by Yoshida ascites cells (for comparable cell and drug concentrations).
In those patients who responded to It should be noted that lymphocytes from R.P., when first tested, failed to degrade chlorambucil and at this time the patient was responding to treatment. When examined one year later lymphocytes from this patient did degrade the drug and treatment then proved clinically ineffective. In the case of G.S., in vitro testing on 2 occasions in 1968 suggested that this patient would be sensitive to chlorambucil, and this proved to be the case clinically. However, subsequent tests 3 years later indicated that this patient's lymphocytes were now degrading the drug though G.S. continued to respond to treatment. Although this behaviour represents the single exception to the classification presented above, G.S. will be followed up on this in vitro screen in the event that he may subsequently develop resistance to treatment.
This simple test procedure may provide a rapid means of assessing a patient's potential response to chemotherapy. Recently other workers have proposed an in vitro assay system to detect the sensitivity of CLL lymphocytes to chlorambucil (Lawler, Lele and Pentycross, 1971 ). This procedure is based on the survival of cells cultured continuously in the presence of the drug. Its disadvantage is the greater time required (5 days) for assessment of response. The present method provides a result in a few hours.
